theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Dermatology

Morphea   

Questions discussed in this category


What is your approach to a patient with generalized morphea, no systemic involvement but a positive RNA Polymerase III?
3 Answers available

Is morphea, cutaneous scleroderma, with no organ involvement a contraindication for radiation in early stage breast cancer as part of breast conservation therapy?
3 Answers available

Is there a role for IVIG in the treatment of active morphea refractory to immunosuppressive agents?
1 Answer available
247121533512922


Papers discussed in this category


Eur J Dermatol,
Response of recalcitrant generalized morphea to intravenous immunoglobulins (IVIg): three cases and a review of the literature.

Arthritis care & research, 2018-10
Impact of Radiation Therapy on Scleroderma and Cancer Outcomes in Scleroderma Patients With Breast Cancer.

Breast Care (Basel), 2019 Aug 16
Incidence of Morphea following Adjuvant Irradiation of the Breast in 2,268 Patients.

Rheumatology (Oxford, England), 2017-11-01
RNA polymerase III-positive systemic sclerosis in a patient with circumscribed morphea.

Related Topics in Dermatology

  • Lung Cancer
  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Gastrointestinal Cancers
  • Genitourinary Cancers
  • Melanoma/Skin Cancer

Copyright © 2025 theMednet
All Rights Reserved.